RNU7-153P

Across TCGA pan-cancer cohorts, RNU7-153P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU7-153P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU7-153P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-153P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

KIRC, OV, and BLCA are the cancer types where RNU7-153P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.205	0.791	<.001	108	view →
OV	OS	Tertile	II,III,IV	0.330	0.843	.002	54	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
STAD	OS	Tertile	III,IV	0.264	0.632	.019	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.374	.043	12	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU7-153P–KIRC (OS)

Open the KIRC breakdown →